Summary
The cells of tumours induced by many oncogenic DNA viruses, or cells transformed in vitro, contain virus-specific T and transplantation antigens; these have been described for SV40 virus, polyoma virus and adenoviruses. The (Ellerman and Bang, 1908) , a profusion of other viruses have been shown to cause cancer in animals. The virus-induced malignancies include leukaemias, lymphomas, sarcomas and carcinomas, and the animals affected include mice, hamsters, rabbits, chickens and monkeys (Rapp and Reed, 1977) . There is no objective reason why man should be excluded from the list of species affected by cancers caused by viruses; however, the ethics which prevent experimentation and the lack of inbred lines available in other species, and which have proved crucial in many experiments, has prohibited the direct experimental approach used in animal studies. This has required investigators to use indirect methods of investigation, which can provide circumstantial evidence of association but cannot afford proof that viruses cause cancer. The oncogenic viruses of animals include both RNA and DNA viruses classified in a number of different groups (Green, 1977) . Researchers (Todaro and Huebner, 1972; Klein, 1972) ; however, the strongest case at the present time is for DNA viruses, and the methods used for these investigations are animal studies, the transformation of animal and human cells grown in tissue culture, the detection of virus or virus-specific nucleic acid in cancer cells and the presence of viral antibodies in patients with malignant disease (Rapp and Reed, 1977 (Lucke, 1938; Churchill and Briggs, 1967) , and at least 2 monkey herpesviruses which can induce lymphomas when inoculated into monkeys of a different species. In addition, the herpesviruses include 2 infective agents of man that have been implicated in human malignant disease; these are the Epstein-Barr virus associated with Burkitt's lymphoma (Zur Hausen, 1975) , and herpesvirus type 2 which has been associated with carcinoma of the cervix (Nahmias et al., 1970 (Habel and Eddy, 1963; Potter and Oxford, 1970 (Pope and Rowe, 1964) or by complement-fixation tests (Black et al., 1963) . The results of crosscomplement fixation tests for T antigen from tumour cells induced by adenovirus 12, SV40 and CELO virus are shown in Table 3 . (Casto, 1968; Sambrook, 1972) ; transformed animal cells can be shown to be tumorigenic by inoculating these cells into syngeneic animals and producing tumours (Rabson and Kirschstein, 1962) . These techniques provide a method for studying the transformation of human cells; however, these cells cannot be proved to be tumorigenic, but from animal studies the in vitro property which correlates best with tumorigenicity is the loss of contact inhibition. Thus, transformed cells grow in vitro to produce densely packed, multilayered colonies easily recognized by the naked eye; and this provides a measurement of cancerous changes of human cells (Jensen, Koprowski and Ponten, 1963; Todaro and Aaronson, 1968) . Human cells can be transformed by SV40 virus (Jensen et al., 1963) but adenovirus 12 transformants are unstable (Todaro and Aaronson, 1968 Green and Swift, 1966) . Comparison of the susceptibility of fibroblasts from different patients to transformation by SV40, and the induction of virus-specific T antigen, which parallels this finding (Aaronson, 1970) , has shown significant differences. The results obtained using cells from 24 subjects are shown in Table 4 (Setlow, 1978 (Aaronson, 1970 (Green, 1977) . This protein has been identified as the 'T' antigen which has a molecular weight of approximately 70 000 and binds to DNA. The 'T' antigen of transformed cells is different from the antigen form found in productively infected cells (Carroll and Smith, 1976) and, from genetic studies, the protein has been shown to be essential to the transformation process (Butel, Brugge and Noonan, 1974 (Green, 1977) (Darai and Munk, 1973 (Munoz, 1973; Wentz et al., 1975) .
(b) Properties of HSV-2 transformed cells. Cells transformed by HSV-2 have similar growth properties to cells transformed by other DNA viruses (Rapp and Westmoreland, 1976) , and do not contain infective virus (Skinner, 1976; Duff, Doller and Rapp, 1973) . Analysis of transformed cell DNA has shown the presence 3-32% of the HSV-2 genome present in 1-5 copies (Frankel et al., 1976) , and this is consistent with the finding that transformation of mouse cells can be accomplished with a fraction of HSV-2 DNA (Maitland-.and McDougall, 1977) . (Gupta and Rapp, 1977) . Cells transformed in vitro by HSV-2 frequently produce tumours when inoculated into syngeneic animals; the tumours from the most oncogenic of transformed cells grow rapidly, are encapsulated with much central necrosis and metastasize to the lung and later to other organs (Fig. 1) . The histogenesis of the tumour is variable, depending probably on the nature of the original transformed cell, but are most commonly described as fibrosarcomas (Boyd, 1975 (Duff et al., 1973) : this later finding is quite distinct from the behaviour of SV40 or adenovirus-induced tumours. Serum from tumour-bearing hamsters has been reported to contain HSV neutralizing antibody (Rapp and Westmoreland, 1976) ; however, no antibody was found in sera from hamsters inoculated with cloned cell lines (Boyd, 1975; Skinner, 1976 (Kessler, 1976 ). In addition, the incidence is relatively high among women whose husbands have penile cancer (Martinez, 1969) , among prostitutes and in association with venereal diseases (Rojel, 1953) and in the wives of men whose first wives died of carcinoma of the cervix (Kessler, 1976) . These findings have been interpreted as signifying that carcinoma of the cervix is caused by a venereallytransmitted factor; indeed, the evidence is held to point to the existence of high-risk males who are most likely to transmit the agent of the disease (Singer, Reid and Coppleson, 1975; Kessler, 1976) .
The nature of the transmitted agent is not known; from experiments of cell transformation the most probable agent would be nucleic acid, either as viral or sperm DNA (Rapp and Westmoreland, 1976; Singer and Stevenson, 1972) . In addition to the above epidemiological findings there is evidence for the existence of high-risk females. The production of a1-antitrypsin is genetically controlled by Pi alleles, and subjects possessing the Pis or Piz phenotypes produce low levels of this serum protein and number only 8% of the population; in contrast, these phenotypes occur with significantly higher frequency in patients with carcinoma of the cervix (A. Singer and A. M. Ward, personal communication).
(b) Virus isolation. Herpesvirus infection is common in man, and serological evidence of past infection can be demonstrated in over 90% of adults; however, the majority of infections are by HSV-1, and antibody to HSV-2 is demonstrable in only 15-25% of normal adults (Skinner, Whitney and Hartley, 1977; Christensen and Epsmark, 1976 lesions, but not from the same areas during remission, and occasionally from the sacral ganglia of cadavers. Evidence of an increasingly high incidence of HSV-2 infection in patients attending special clinics has been obtained in many studies (Rawls, Adam and Melnick, 1973) . In addition, HSV-2 was isolated from the genital tract of 1-6% of asymptomatic women and 8-29% of similar men; the reason for this sex difference is not known (Centifanto, Drylie and Deardourff, 1972; Kleger et al., 1968) .
Investigation of HSV-2 infection in patients with dysplasia and carcinoma of the cervix has revealed histological evidence of HSV infection in 23-7% of biopsy specimens. HSV-2 has been recovered from cervical cancer cells grown in tissue culture at a relatively high pH (Aurelian, 1973) . From laboratory studies of HSV-2 and other DNA virus transformed cells outlined above, the recovery of infective HSV-2 virus from carcinoma cells argues against this virus as a cause of the malignancy. In addition, since cells transformed in vitro by HSV-2 show increased resistance to HSV-2 infection (Darai and Munk, 1973) , the presence of virus in carcinoma cells argues against this viral aetiology for this cancer.
Papovavirus and adenovirus-induced tumour cells contain variable amounts of viral DNA, even in the absence of infective virus, and similar results have been found for HSV-2 transformed hamster cells (Frankel et al., 1976) . Thus, the identification of a fragment of HSV-2 DNA in cells from a human cervical tumour was highly provocative (Frankel et al., 1972) ; however, this finding has not been confirmed. In studies of hamster cells transformed by HSV-2, Skinner (1976) (Rawls et al., 1973) . The relatively higher incidence of neutralizing antibody to HSV-2 in patients with carcinoma ofthe cervix is not seen in patients with other malignancies. In addition to neutralizing antibody, Aurelian, Strnad and Smith (1977) reported a significantly higher incidence of antibody to the early, virus-specific structural protein AG-4, and Notter and Docherty (1976) to an early product of HSV-2 infected hamster cells in sera from patients with carcinoma of the cervix than in controls; the antibody has been suggested as IgG (Falaky and Vestergaard, 1977) and non-IgG (Thiry et al., 1977 
